SULFATES DE CHOLESTEROL OXYGENES POUR LE TRAITEMENT DE TROUBLES CAUSES PAR UNE DIMINUTION DE L'ACTIVITE DE LA LEPTINE OU UN TROUBLE DE STOCKAGE DES LIPIDES, OU LES DEUX
Methods and compositions are provided for the prevention and/or treatment of symptoms associated with lipid accumulation disorders caused by attenuated leptin activity and by lipid storage disorders. The methods involve administering at least one oxygenated cholesterol sulfate (OCS) to a subject with the disorder. The disorder may be acquired or congenital (hereditary).